407 related articles for article (PubMed ID: 18663343)
21. The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial.
Bose K
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):209-13. PubMed ID: 10389124
[TBL] [Abstract][Full Text] [Related]
22. Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study.
Tariq M; Akhtar N; Ali M; Rao S; Badshah M; Irshad M
J Pak Med Assoc; 2005 May; 55(5):202-4. PubMed ID: 15960286
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and treatment of low-back pain because of paraspinous muscle spasm: a physician roundtable.
McCarberg BH; Ruoff GE; Tenzer-Iglesias P; Weil AJ
Pain Med; 2011 Nov; 12 Suppl 4():S119-27. PubMed ID: 22085373
[TBL] [Abstract][Full Text] [Related]
25. Use of medications in the treatment of acute low back pain.
Malanga GA; Dennis RL
Clin Occup Environ Med; 2006; 5(3):643-53, vii. PubMed ID: 16963380
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant.
Ito T; Hori M; Furukawa K; Karasawa T; Kadokawa T
Arch Int Pharmacodyn Ther; 1985 May; 275(1):105-22. PubMed ID: 3839647
[TBL] [Abstract][Full Text] [Related]
27. [A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema].
Ueno T; Kawana S
Arerugi; 2007 Jul; 56(7):709-13. PubMed ID: 17671415
[TBL] [Abstract][Full Text] [Related]
28. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience.
Katz WA; Dube J
Clin Ther; 1988; 10(2):216-28. PubMed ID: 3078905
[TBL] [Abstract][Full Text] [Related]
29. Choosing a skeletal muscle relaxant.
See S; Ginzburg R
Am Fam Physician; 2008 Aug; 78(3):365-70. PubMed ID: 18711953
[TBL] [Abstract][Full Text] [Related]
30. [Treatment experience with chronic spinal pain in involutional osteoporosis].
Passeri M; Baroni MC; Pedrazzoni M; Vescovi PP
Ann Ital Med Int; 1992; 7(3 Suppl):137S-153S. PubMed ID: 1297392
[TBL] [Abstract][Full Text] [Related]
31. Serum concentration of eperisone hydrochloride correlates with QT interval.
Yamagiwa T; Morita S; Amino M; Miura N; Saito T; Inokuchi S
Am J Emerg Med; 2014 Jan; 32(1):75-7. PubMed ID: 24135462
[TBL] [Abstract][Full Text] [Related]
32. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats.
Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y
Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816
[TBL] [Abstract][Full Text] [Related]
33. The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
Gould EM; Jensen MP; Victor TW; Gammaitoni AR; White RE; Galer BS
Clin J Pain; 2009 Feb; 25(2):116-22. PubMed ID: 19333156
[TBL] [Abstract][Full Text] [Related]
34. [Effects of back pain treatment with tizanidine].
Górska J
Ortop Traumatol Rehabil; 2005 Jun; 7(3):306-9. PubMed ID: 17611479
[TBL] [Abstract][Full Text] [Related]
35. Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry.
Melilli B; Piazza C; Vitale DC; Marano MR; Pecori A; Mattana P; Volsi VL; Iuculano C; Cardì F; Drago F
Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):71-8. PubMed ID: 21448778
[TBL] [Abstract][Full Text] [Related]
36. Low back pain.
Monajati SD; Clement J; Cave DG
Manag Care Interface; 1999 Aug; 12(8):52-4. PubMed ID: 10621093
[TBL] [Abstract][Full Text] [Related]
37. Effect of locally administered lornoxicam in the management of low back pain after lumbar epidural anesthesia: a double-blind, randomized, controlled study.
Muslu B; Usta B; Muslu S; Yeşilay A; Gözdemir M; Sert H; Demircioglu R
Minerva Anestesiol; 2009 Sep; 75(9):494-7. PubMed ID: 19461565
[TBL] [Abstract][Full Text] [Related]
38. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist.
Okada M; Nose T
Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262
[TBL] [Abstract][Full Text] [Related]
39. Oral muscle relaxant may induce immediate allergic reactions.
Hur GY; Hwang EK; Moon JY; Ye YM; Shim JJ; Park HS; Kang KH
Yonsei Med J; 2012 Jul; 53(4):863-5. PubMed ID: 22665359
[TBL] [Abstract][Full Text] [Related]
40. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
Monster AW; Herman R; Meeks S; McHenry J
Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
